Stephen Gunstream Buys 26,000 Shares of Alpha Teknova (NASDAQ:TKNO) Stock

Alpha Teknova, Inc. (NASDAQ:TKNO) CEO Stephen Gunstream bought 26,000 shares of the business’s stock in a transaction dated Friday, March 6th. The stock was acquired at an average cost of $2.15 per share, for a total transaction of $55,900.00. Following the completion of the acquisition, the chief executive officer directly owned 269,497 shares in the company, valued at approximately $579,418.55. This trade represents a 10.68% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Alpha Teknova Stock Up 21.7%

Alpha Teknova stock opened at $2.58 on Wednesday. The stock’s 50 day moving average price is $2.84 and its 200 day moving average price is $4.13. The company has a market cap of $138.26 million, a PE ratio of -7.82 and a beta of 0.39. The company has a debt-to-equity ratio of 0.19, a current ratio of 4.58 and a quick ratio of 3.64. Alpha Teknova, Inc. has a 1-year low of $1.91 and a 1-year high of $7.48.

Alpha Teknova (NASDAQ:TKNO) last issued its quarterly earnings data on Thursday, February 26th. The company reported ($0.09) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.09). The business had revenue of $9.98 million during the quarter, compared to analysts’ expectations of $9.62 million. Alpha Teknova had a negative net margin of 42.59% and a negative return on equity of 23.32%. On average, sell-side analysts predict that Alpha Teknova, Inc. will post -0.58 EPS for the current fiscal year.

Hedge Funds Weigh In On Alpha Teknova

Several institutional investors and hedge funds have recently modified their holdings of the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in Alpha Teknova during the second quarter worth $29,000. JPMorgan Chase & Co. boosted its stake in shares of Alpha Teknova by 123.1% during the 2nd quarter. JPMorgan Chase & Co. now owns 8,163 shares of the company’s stock worth $40,000 after acquiring an additional 4,504 shares in the last quarter. Larson Financial Group LLC boosted its stake in shares of Alpha Teknova by 58.5% during the 3rd quarter. Larson Financial Group LLC now owns 9,387 shares of the company’s stock worth $58,000 after acquiring an additional 3,464 shares in the last quarter. ProShare Advisors LLC acquired a new position in shares of Alpha Teknova during the 4th quarter valued at about $38,000. Finally, Whalen Wealth Management Inc. bought a new position in shares of Alpha Teknova in the 3rd quarter valued at approximately $77,000. 13.81% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

TKNO has been the subject of several analyst reports. Zacks Research raised Alpha Teknova to a “hold” rating in a research report on Wednesday, December 10th. Weiss Ratings reissued a “sell (d-)” rating on shares of Alpha Teknova in a report on Wednesday, January 21st. One research analyst has rated the stock with a Strong Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $8.00.

About Alpha Teknova

Alpha Teknova, Inc (NASDAQ: TKNO) is a life science tools and reagents company that develops, manufactures and distributes proprietary products to support research, drug discovery and biomanufacturing. Its offerings target academic institutions, pharmaceutical and biotechnology firms, and diagnostic developers, with a focus on high-purity reagents and optimized workflows designed to accelerate molecular biology and protein science applications.

The company’s portfolio includes molecular biology reagents, cell culture buffers, in vitro translation kits, custom recombinant proteins, high-throughput screening buffers and other specialized formulations.